Factory Supply High Quality CAS 4956-37-0 Estradiol Enanthate

Name: Factory Supply High Quality CAS 4956-37-0 Estradiol Enanthate
Brand: Qingdao Little Fox Biological and Technology Co., Ltd.
SKU: 1925143002

Shandong, ChinaQingdao Little Fox Biological and Technology Co., Ltd.

US$1,900.00-2,500.00

1 kg

Product profile

Powder

Yes

Customized

Non-Customized

Certification

GMP, USP

Model NO.

LF4956-37-0

Suitable for

Adult

State

Powder

Purity

>99%

Product Name

Oestradiol 17-Heptanoate

CAS No.

30123-17-2

Other Name

Oestradiol 17-Heptanoate;

Mf

C25h36o3

Molecular Weight

384.56

Einecs No.

225-599-8

Application

Pharmaceutical Intermediates

Storage

Cool Dry Place

Appearance

Powder

Packing

Foil Bag or Drum

Delivery

by Courier, Sea, Air, Special Private Channel

Color

White Powder

Solubility

DMSO: > 20mg/Ml

Sample

> 1g

Price

Negotiable

Transport Package

Aluminum Foil Bag or as Your Requirement

Specification

25kg kraft bag or fiber drum

Trademark

Little Fox

Origin

China

HS Code

3004320022

Production Capacity

100000

Company profile

Qingdao Little Fox Biological and Technology Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2016-09-28Nearest Port: QingdaoAverage Response Time: ≤2.31hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP, DAP

AI-Powered supplier vetting

SummaryThe supplier is a trading company focused on chemical products, primarily offering customization based on samples without any significant innovation capability or R&D focus. Their after-sales services lack formal procedures, and they do not participate in offline trade shows or maintain overseas warehouses. Financial data is consistently reported over the past three years, but there's no information on certification holdings or customer cases.

Supplier typeThe supplier is a trading company with a focus on chemical products, excluding hazardous chemicals. It operates as a Limited Company and is involved in the production and wholesale of chemical and pharmaceutical intermediates.

After-Sales capabilityThe supplier lacks formal written procedures or records for after-sales service capabilities, including handling customer complaints, which indicates a lack of structured after-sales service processes.

Financial creditThe supplier has consistently reported financial data over the past three years, indicating a stable financial record.

R&D capabilityThe supplier does not engage in R&D activities for new products, ODM services, or provide SDKs, suggesting limited innovation capability.

Customization capabilityThe supplier offers customization services based on samples, indicating an ability to tailor products according to specific client requirements.